At Vivi, alchemy begins with the identification of novel molecular targets. Through high-throughput screening, and data-driven analytics, we illuminate pathways and unveil targets, setting the stage for transformative therapeutic interventions.
Utilizing state-of-the-art bioinformatics tools, we analyze binding affinities and structure-activity relationships to efficiently refine lead compounds, ensuring optimal interaction with the biological target.
We engage in rational drug design and medicinal chemistry to optimize lead compounds for potency, selectivity, and pharmacokinetic properties, setting the cornerstone for promising drug candidates.
At Vivi, we engineer efficiency. By minimizing attrition rates and maximizing the productivity of the drug discovery pipeline, we ensure cost optimization without compromising the scientific integrity.